e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Y-Mabs Therapeutics Inc
(NQ:
YMAB
)
11.59
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9
Open
11.59
Bid (Size)
4.640 (2)
Ask (Size)
18.42 (1)
Prev. Close
11.59
Today's Range
11.59 - 11.59
52wk Range
5.040 - 20.90
Shares Outstanding
44,789,076
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Examining the Future: Y-mAbs Therapeutics's Earnings Outlook
November 07, 2024
Via
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio.
Via
Benzinga
Performance
YTD
+68.70%
+68.70%
1 Month
-18.95%
-18.95%
3 Month
-5.08%
-5.08%
6 Month
-2.19%
-2.19%
1 Year
+120.76%
+120.76%
More News
Read More
Navigating 8 Analyst Ratings For Y-mAbs Therapeutics
September 09, 2024
Via
Benzinga
Assessing Y-mAbs Therapeutics: Insights From 5 Financial Analysts
August 13, 2024
Via
Benzinga
Why Y-mAbs Therapeutics Stock Got Mashed on Monday
August 12, 2024
Via
The Motley Fool
YMAB Stock Earnings: Y-mAbs Therapeutics Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
Via
InvestorPlace
Cracking The Code: Understanding Analyst Reviews For Y-mAbs Therapeutics
March 06, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
Earnings Outlook For Y-mAbs Therapeutics
February 28, 2024
Via
Benzinga
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
August 12, 2024
Via
Benzinga
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Stock of Y-mAbs Therapeutics, Inc. - YMAB
July 22, 2024
From
Pomerantz LLP
Via
GlobeNewswire
MSC Industrial Direct, Radius Recycling And 3 Stocks To Watch Heading Into Tuesday
July 02, 2024
Via
Benzinga
YMAB Stock Earnings: Y-mAbs Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Earnings Preview For Y-mAbs Therapeutics
November 10, 2023
Via
Benzinga
4 Analysts Have This to Say About Y-mAbs Therapeutics
August 14, 2023
Via
Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 01, 2024
Via
Benzinga
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
March 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
March 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 29, 2024
Via
Benzinga
Beam Therapeutics Stock Shows Healthy Relative Strength Improvement
February 16, 2024
Via
Investor's Business Daily
Micro Marvel - Y-Mabs Therapeutics
February 13, 2024
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
January 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 12, 2024
Via
Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert
